Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor–Dependent Signaling

This publication has 42 references indexed in Scilit:

• Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
  Frontiers in Immunology, 2012
• Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma
  Clinical Cancer Research, 2011
• Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms
  Laboratory Investigation, 2011
• Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy
  The American Journal of Pathology, 2010
• Recent advances in the regulation of cholangiocarcinoma growth
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
• H3 Histamine Receptor–Mediated Activation of Protein Kinase Cα Inhibits the Growth of CholangiocarcinomaIn vitroandIn vivo
  Molecular Cancer Research, 2009
• Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
• Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF‐κB and induction of apoptosis
  International Journal of Cancer, 2009
• What Improves with Increased Missing Data Imputations?
  Structural Equation Modeling: A Multidisciplinary Journal, 2008
• Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP₃/CaMK I/CREB pathway
  American Journal of Physiology-Cell Physiology, 2008